<DOC>
	<DOC>NCT01612806</DOC>
	<brief_summary>To evaluate the effectiveness of PriMatrix, PriMatrix Ag, and Standard of Care in the treatment of venous leg ulcers (VLUs).</brief_summary>
	<brief_title>A Multi-center, Prospective, Randomized Study With PriMatrix and PriMatrix Ag for the Treatment of Venous Leg Ulcers</brief_title>
	<detailed_description>Healing percentages</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<mesh_term>Postphlebitic Syndrome</mesh_term>
	<mesh_term>Postthrombotic Syndrome</mesh_term>
	<criteria>Men or women ≥ 18 years of age Anklebrachial index (ABI) &gt; 0.80 Study wound 264 cm2 surface area Wound does not exhibit a greater than 50% reduction in surface area during the screening period Suspected or confirmed signs/symptoms of wound infection Hypersensitivity to bovine collagen Body Mass Index (BMI) ≥ 45</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>